1. Home
  2. TECH vs PR Comparison

TECH vs PR Comparison

Compare TECH & PR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • PR
  • Stock Information
  • Founded
  • TECH 1976
  • PR 2015
  • Country
  • TECH United States
  • PR United States
  • Employees
  • TECH N/A
  • PR N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • PR Oil & Gas Production
  • Sector
  • TECH Health Care
  • PR Energy
  • Exchange
  • TECH Nasdaq
  • PR Nasdaq
  • Market Cap
  • TECH 11.3B
  • PR 9.8B
  • IPO Year
  • TECH 1989
  • PR 2016
  • Fundamental
  • Price
  • TECH $73.17
  • PR $13.61
  • Analyst Decision
  • TECH Buy
  • PR Strong Buy
  • Analyst Count
  • TECH 8
  • PR 16
  • Target Price
  • TECH $82.00
  • PR $18.87
  • AVG Volume (30 Days)
  • TECH 795.5K
  • PR 7.9M
  • Earning Date
  • TECH 01-30-2025
  • PR 11-06-2024
  • Dividend Yield
  • TECH 0.44%
  • PR 2.57%
  • EPS Growth
  • TECH N/A
  • PR 85.31
  • EPS
  • TECH 0.95
  • PR 1.65
  • Revenue
  • TECH $1,171,583,000.00
  • PR $4,827,339,000.00
  • Revenue This Year
  • TECH $7.67
  • PR $66.59
  • Revenue Next Year
  • TECH $9.38
  • PR $6.66
  • P/E Ratio
  • TECH $77.07
  • PR $8.24
  • Revenue Growth
  • TECH 2.41
  • PR 74.92
  • 52 Week Low
  • TECH $61.16
  • PR $12.59
  • 52 Week High
  • TECH $85.57
  • PR $18.28
  • Technical
  • Relative Strength Index (RSI)
  • TECH 46.90
  • PR 33.92
  • Support Level
  • TECH $69.48
  • PR $14.69
  • Resistance Level
  • TECH $77.62
  • PR $14.19
  • Average True Range (ATR)
  • TECH 2.45
  • PR 0.42
  • MACD
  • TECH -0.45
  • PR -0.22
  • Stochastic Oscillator
  • TECH 41.28
  • PR 10.94

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About PR Permian Resources Corporation

Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization and development of oil and liquids-rich natural gas assets. The Company's assets and operations are primarily concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.

Share on Social Networks: